"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...

TAMPA, FL / ACCESS Newswire / June 13, 2025 / NeuroEM Therapeutics®, an award-winning clinical-stage biotechnology research ...

After struggling to raise funds in Florida, Tampa-based biotech startup NeuroEM found an out-of-state partner to help push ...

Scientists have uncovered how exercise directly influences brain health in Alzheimer's disease by pinpointing the exact brain ...

Scientists have found that lemborexant not only increased restorative sleep in male mice but also reduced levels of toxic tau ...

Mayo Clinic researchers validated an FDA-approved blood test that diagnoses Alzheimer’s disease with 95% sensitivity and 82% ...

Alzheimer’s Association. In some ways, such a force introduced as “recently” as 1980 may not seem long, given the impact ...

Statins, long hailed for lowering cholesterol, might offer an unexpected benefit beyond heart health—they could help slow ...

Few people in the UK with early stage Alzheimer's disease are likely to be suitable for the latest drugs which aim to halt ...

Although facing a potential Alzheimer’s diagnosis is daunting, waiting only limits a person’s options. If you’re concerned ...